gepanttilääkkeiden
Gepanttilääkkeet, also known as gepants, are a class of oral medications used for the acute treatment of migraine headaches. These drugs work by targeting the calcitonin gene-related peptide (CGRP) pathway, which is known to play a significant role in the development of migraine. Unlike older migraine medications that often constrict blood vessels, gepants are designed to block the action of CGRP without causing vasoconstriction, potentially leading to fewer cardiovascular side effects.
The development of gepants represents a novel approach to migraine therapy. Traditional acute migraine treatments, such
Several gepant medications have been approved by regulatory agencies for use in the treatment of migraine.